GSK Multiple Myeloma Drugs DREAMM Comeback Continues With Phase 3 Data at ASH
| TEMQX Fund | USD 14.41 0.27 1.84% |
Slightly above 61% of Mutual Quest's investor base is looking to short. The analysis of overall sentiment of trading Mutual Quest mutual fund suggests that many investors are alarmed at this time. Mutual Quest's investing sentiment can be driven by a variety of factors including economic data, Mutual Quest's earnings reports, geopolitical events, and overall market trends.
Mutual |
Results from the Phase 3 DREAMM-7 study show GSK drug Blenrep is helping multiple myeloma patients live longer compared to treatment with blockbuster Johnson Johnson drug Darzalex. The data, presented Monday during the annual meeting of the American Society of Hematology, are part of a submission now under FDA review that could lead to Blenreps return to the market.
Read at medcitynews.com
 |
Mutual Quest Fundamental Analysis
We analyze Mutual Quest's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mutual Quest using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mutual Quest based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
One Year Return
One Year Return Comparative Analysis
Mutual Quest is currently under evaluation in one year return among similar funds. One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
Mutual Quest Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mutual Quest mutual fund to make a market-neutral strategy. Peer analysis of Mutual Quest could also be used in its relative valuation, which is a method of valuing Mutual Quest by comparing valuation metrics with similar companies.
Peers
Mutual Quest Related Equities
| GGHYX | Invesco Global | 0.16 |
| ||
| BGHDX | Baillie Gifford | 0.17 |
| ||
| LOGSX | Live Oak | 1.52 |
| ||
| SWHFX | Schwab Health | 1.60 |
| ||
| BHSRX | Blackrock Health | 2.15 |
| ||
| BHCHX | Baron Health | 2.77 |
|
Other Information on Investing in Mutual Mutual Fund
Mutual Quest financial ratios help investors to determine whether Mutual Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mutual with respect to the benefits of owning Mutual Quest security.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |